ClinicalTrials.govpublic full text
Irinotecan Study For Cervical Cancer
uterine cervical neoplasms, weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892404
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.